Get started

Buy-signal

CRXT Clarus Therapeutics Bullish ReversalCRXT Clarus Therapeutics had 3 green days after its sell-off to all time low. This should signal a reversal pattern. Clarus Therapeutics has the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions called JATENZO. The fist target is the $1.1 private placement offering price and then the $2.10 resistance. Few months ago they had another private placement at $4.96 per unit, so we can take that into consideration as well. Needham & Company LLC has a Price Target of $8 for CRXT (that is the ultimate goal). I think it can easily double from here. Looking forward to read your opinion about it.
CLong
by TopgOptions
VRM Vroom ready for an Epic Squeeze!Have you seen so many bullish divergencies on a daily chart before? Neither do i! A bullish divergence occurs when prices fall to a new low while an oscillator fails to reach a new low, demonstrating that bears are losing power, and that bulls are ready to control the market again. A bullish divergence marks the end of a downtrend typically. What should we expect from the May 9th earnings? - revenue growth! last quarter their Ecommerce revenue was $738.7 million, up 159% year over year; gross profit was also up a lot, 64% YoY! - a strong financing business! On February 01, 2022, Vroom announced the successful completion of its acquisition of United Auto Credit Corporation (UACC), a proven leader in automotive finance for $300 Mil. Soon after the news above was released, on 2/3/2022, Bank of America set a price target for VRM of $30.00 So how come it is trading at $1.66??? Well, 29.48% of the share float is Shorted! Big institutional owners like Vanguard, Blackrock , Morgan Stanley , JPMorgan Chase have average entries at $40! And many of them had recently averaged down their investment, like Goldman Sachs which reported on 2/17/2022 an increase of 104.5% in their ownership in VRM , respectively 1,753,977 shares worth $18.93Mil for a total of 1.281% of the company. Their average is now $22.55. So if they are happy with a 22 average, how come we don`t we buy it at $1.66? VRM has a Price to book ratio of 0.24 now. A P/B ratio less than 1 means that the stock is trading at less than its book value, it`s way undervalued! the Price to Sales ratio is only 0.07! By comparison, its rival, CVNA (Carvana), has a P/S of 1.16. Based on Q4 Financials, If they liquidated the inventory, cash in on all receivables and pay off the $600M senior note, each shareholder will receive approximatively $6.5 per share. If we look at the daily timeframe , VRM formed a falling wedge pattern which is extremely bullish as you know, on an oversold area, 25 on the RSI . Institutional ownership in VRM is high, 92.19% 52 Week Range 1.58 - 48.80 Market Cap of only $235.47Mil! Can be a buyout at this point! 2021 Revenue: $3.18Bil All things considered, fundamental and technical analysis , my short term price target for VRM is $5.95, i think it`s trading so low because it`s heavily shorted by the hedge funds, to have a better average on their entry. Looking forward to read your opinion about it!
NASDAQ:VRMLong
by TopgOptions
8
EPIK Prime Double Bottom “Animoca Brands’ investment into EPIK Prime is part of an ongoing and powerful synergistic partnership,” said Animoca Brands co-founder and chairman Yat Siu. “Together we are stronger. We look forward to expanding our presence in brand licensing, gaming, and metaverse ecosystems.” EPIK Prime Token Will Drive Development and Advancement of Cross-Chain Gaming Projects and Protocols around NFTs and Brand Licensing for Metaverse Digital Merchandise. EPIK Prime is backed by Animoca Brands. My short term price target is $0.21. Looking forward to read your opinion about it.
Long
by TopgOptions
1
VRM all time low | Q1 Earnings on May 9What should we expect from the earnings? - revenue growth! last quarter their Ecommerce revenue was $738.7 million, up 159% year over year; gross profit was also up a lot, 64% YoY! - a strong financing business! On February 01, 2022, Vroom announced the successful completion of its acquisition of United Auto Credit Corporation (UACC), a proven leader in automotive finance for $300 Mil. Soon after the news above was released, on 2/3/2022, Bank of America set a price target for VRM of $30.00 So how come it is trading at $1.66??? Well, 29.48% of the share float is Shorted! Big institutional owners like Vanguard, Blackrock , Morgan Stanley , JPMorgan Chase have average entries at $40! And many of them had recently averaged down their investment, like Goldman Sachs which reported on 2/17/2022 an increase of 104.5% in their ownership in VRM , respectively 1,753,977 shares worth $18.93Mil for a total of 1.281% of the company. Their average is now $22.55. So if they are happy with a 22 average, how come we don`t we buy it at $1.66? VRM has a Price to book ratio of 0.24 now. A P/B ratio less than 1 means that the stock is trading at less than its book value, it`s way undervalued! the Price to Sales ratio is only 0.07! By comparison, its rival, CVNA (Carvana), has a P/S of 1.16. Based on Q4 Financials, If they liquidated the inventory, cash in on all receivables and pay off the $600M senior note, each shareholder will receive approximatively $6.5 per share. If we look at the daily timeframe , VRM formed a falling wedge pattern which is extremely bullish as you know, on an oversold area, 25 on the RSI . Institutional ownership in VRM is high, 92.19% 52 Week Range 1.58 - 48.80 Market Cap of only $235.47Mil! Can be a buyout at this point! 2021 Revenue: $3.18Bil All things considered, fundamental and technical analysis, my short term price target for VRM is $5.95, i think it`s trading so low because it`s heavily shorted by the hedge funds, to have a better average on their entry. Looking forward to read your opinion about it!
NASDAQ:VRMLong
by TopgOptions
2
CRXT 900% Upside Potential According to this analyst Clarus Therapeutics Holdings, Inc. (CRXT) Announced Initiation of Phase 4 Clinical Trial of JATENZO, the first and only FDA-approved oral softgel for testosterone replacement therapy in adult male. On 3/31/2022 Serge Belanger from Needham & Company LLC brokerage set a Buy Rating for CRXT and a Price Target of $8.00, which is 9 times higher than the current price. I think it can easily double. Looking forward to read your opinion about it.
CLong
by TopgOptions
GBPNZD LONG✅TP - green lines ❌SL - red line Entry - yellow line Original Analysis GBPNZD Rising Wedge identified at 22-Apr-14:00 2022 GMT. This pattern is still in the process of forming. Possible bullish price movement towards the resistance 1.94711 within the next couple days. Support Levels 1.9148 Resistance Levels 1.9473 This does not constitute investment advice and does not have regard to the specific needs of any person who may receive it. No warranty is given as to the accuracy or completeness of the information and any person acting on it does so entirely at their own risk.
Long
by pmfxideas
WAR at all time lowWAR WeStarter is a cross-chain token initial swap platform which selects high-quality crypto projects that need fundraising before listing to major exchanges. The first financing of WeStarter (WAR) was completed on April 15th 2021, and the participated investment institutions include Continue Capital, SevenX Ventures, NGC Ventures, AU21 Capital, Spark Digital Capital, LD Capital, Power Law Capital, Kyros Ventures, DoraHacks Ventures, SkyVentures, DEFI TIMES CAPITAL and others. Continue Capital also invested in Cosmos ATOM, ChainLink, Polkadot , Tezos, OX, Near, Graph. Algorand, Certik, Zilliqa , Hedera Hashgraph, Fusion and many others. So the project is legit. Under 1Mil mk cap.
WLong
by TopgOptions